Related Experiment Video
Updated: Aug 11, 2025

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Vasospastic Angina: A Contemporary Review of its Pathophysiology, Diagnosis and Management
Aish Sinha1, Haseeb Rahman1, Divaka Perera1
1The British Heart Foundation Centre of Excellence and the National Institute for Health and Care Research Biomedical Research Centre at the School of Cardiovascular Medicine and Sciences, King's College London, London, UK.
Insights
Vasospastic angina (VSA), a cause of chest pain in nearly 40% of patients with non-obstructed coronary arteries (ANOCA), has poorly understood mechanisms and limited treatments. This review summarizes VSA pathophysiology, diagnostics, and current therapeutic options.
Area of Science:
- Cardiology
- Vascular Medicine
- Pathophysiology
Background:
- Angina with non-obstructed coronary arteries (ANOCA) affects nearly 40% of patients undergoing cardiac catheterization.
- Coronary artery spasm, a key cause of ANOCA, leads to vasospastic angina (VSA), impacting quality of life and increasing major adverse cardiac events.
- The underlying mechanisms of VSA remain incompletely understood, limiting effective therapeutic strategies.
Purpose of the Study:
- To provide a comprehensive review of the pathophysiological mechanisms of VSA.
- To summarize current therapeutic options for patients with VSA.
- To critically appraise the diagnostic approaches for suspected VSA.
Main Methods:
- Literature review of recent research on ANOCA and VSA.
- Synthesis of information on VSA pathophysiology, diagnosis, and treatment.
- Critical appraisal of diagnostic and therapeutic strategies.
Main Results:
- VSA is a distinct entity within the ANOCA spectrum, characterized by reversible coronary flow attenuation.
- Current understanding of VSA pathophysiology is limited, contributing to a lack of targeted therapies.
- A surge in research over the past decade has improved insights into VSA.
Conclusions:
- Further research into VSA pathophysiology is crucial for developing improved therapeutic options.
- Accurate diagnosis and timely management of VSA are essential for improving patient outcomes.
- This review consolidates current knowledge, guiding future research and clinical practice in VSA.
Abstract:
Nearly 40% of patients presenting to the catheter laboratory with angina have non-obstructed coronary arteries (ANOCA), an umbrella term that encompasses distinct pathophysiological entities, such as coronary artery spasm. Coronary artery spasm leads to sudden reversible coronary flow attenuation, which clinically manifests as vasospastic angina (VSA). VSA is associated with poor quality of life and an increased risk of major adverse cardiac events. However, the pathophysiological mechanisms underlying this phenomenon are incompletely understood, which has resulted in limited therapeutic options for patients afflicted with this condition. The past decade has seen a surge in new research being conducted in the field of ANOCA and VSA. This review article provides a comprehensive summary of the underlying pathophysiological mechanisms of VSA and the current therapeutic options. We also appraise the current diagnostic approach in patients with suspected VSA.
Related Concept Videos
Angina IV: Management
Angina V: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina III: Clinical Manifestations and Assessment
Peripheral Artery Disease III: Interprofessional Care

